Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telaprevir in Treatment-Experienced Genotype 1 Hepatitis C
NCT01467492Phase 4Terminated
- Sponsor
- Vertex Pharmaceuticals
- Start
- Jan 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of telaprevir in hepatitis C (HCV), sponsored by Vertex Pharmaceuticals. Started Jan 2012; status: terminated.
02
Drugs
telaprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01467492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01467492.